Hyperbaric Oxygen Treatment as Adjuvant Treatment for Frost Injury (FROST)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by Oslo University Hospital.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Oslo University Hospital
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01270477
First received: January 3, 2011
Last updated: April 18, 2011
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of this study is to see weather hyperbaric oxygen treatment is beneficial as adjuvant treatment for frost damage.
The investigators hope to include at least 20 patients in a randomized manner. Half of the patients are randomized to hyperbaric oxygen, and half of the patients are randomized not to have hyperbaric oxygen treatment.
Under hypotheses: The number og surgeries is reduced by hyperbaric oxygen treatment as adjuvant treatment for frost damage. The functional level of the frost damaged patient is better after 6 and 12 months when also treated with hyperbaric oxygen treatment for frost damage.
| Condition | Intervention |
|---|---|
|
Wound (Morphologic Abnormality) |
Other: Hyperbaric oxygen treatment |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Study of the Possible Improvement in Level of Sequela and Amputation/Amputation Level After Frost Injury by the Adjuvant Treatment of Hyperbaric Oxygen. |
Resource links provided by NLM:
Further study details as provided by Oslo University Hospital:
Primary Outcome Measures:
- Hyperbaric oxygen treatment is favorable for tissue regeneration after frost injury. [ Time Frame: From incusion of a patiant through a follow up after 1 year. ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- First: The number of surgeries is reduced with hyperbaric oxygen treatment. [ Time Frame: One year from the enrollment of a patient. ] [ Designated as safety issue: No ]
Second: The level of amputation is further distal on the extremity with hyperbaric oxygen treatment.
Third: The level of function of the damaged bodypart is better after 6 and 12 months with hyperbaric treatment.
| Estimated Enrollment: | 20 |
| Study Start Date: | January 2011 |
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | May 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Hyperbaric oxygen treatment
Hyperbaric oxygen treatment in an hyperbaric oxygen treatment chamber on an recognized treatment table.
|
Other: Hyperbaric oxygen treatment
Hyperbaric oxygen treatment for 2,5 hours at maximum 14 meters (standard table in Norway).
Other Names:
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Age 18-70. Frost damage grade II-IV. Inclusion is needed within 48 hours from time of damage.
Exclusion Criteria:
- Pregnancy. Ventilator treatment. Problems with equalizing. High grade heart failure. Chronic obstructive lung disease of high grade. Treatment over 3 days after time of damage. Serious claustrophobia/psychiatric illness.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01270477
Contacts
| Contact: Helle Midtgaard, MD | 990 15 653 ext +47 | helle@fue.no |
| Contact: Halvard Stave, MD | 95857482 ext +47 | hstave@gmail.com |
Locations
| Norway | |
| Hyperbaric section Oslo University hospital | Recruiting |
| Oslo, Norway, 0407 | |
| Contact: Lene Mathisen, MD mathisen_lene@hotmail.com | |
| Principal Investigator: Helle Midtgaard, MD | |
| Sub-Investigator: Halvard Stave, MD | |
Sponsors and Collaborators
Oslo University Hospital
Investigators
| Study Director: | Knut Ar Kirkeboen, MD Professor | Oslo University hospital, Norway |
More Information
No publications provided
| Responsible Party: | Oslo University hospital, Health south east, Norway |
| ClinicalTrials.gov Identifier: | NCT01270477 History of Changes |
| Other Study ID Numbers: | FROST |
| Study First Received: | January 3, 2011 |
| Last Updated: | April 18, 2011 |
| Health Authority: | Norway: Ethics Committee |
Keywords provided by Oslo University Hospital:
|
Frost injury |
Additional relevant MeSH terms:
|
Congenital Abnormalities Wounds and Injuries |
ClinicalTrials.gov processed this record on May 16, 2013